Musk’s development of brain chips shows the urgency of regulating new technologies

The Food and Drug Administration has authorized Neuralink, a company that belongs to the same owner of Twitter, to test its brain implants on people, reviving the need to systematically regulate new technological tools. Risks and possibilities

The announcement of the approval for Neuralink (Elon Musk’s company), by the Food and Drug Administrationof the possibility of being able to start the experimentation of its brain implants on people is probably destined to arouse discussion and to open, in an even more important way, a debate which in recent years has allowed us to glimpse the possibilities and risks of emerging technologies.